EVOCOR 1.25 MG BOX OF 30 

Treatment of stable, moderate to severe chronic heart failure with reduced systolic ventricular function (ejection fraction ≤ 35%, as determined by echocardiography), as an adjunct to angiotensin-converting enzyme (ACE) inhibitors and diuretics, and optionally digitalis.

Category: Tag:

Description

Specialty EVOCOR
Dosage 1.25 mg
Pharmaceutical Form Film-coated tablet
Presentation Box of 30
Primary Packaging Blister
Specification PVC / PVDC / Aluminium
INN (International Non-proprietary Name) BISOPROLOL
VEIC Classification Cardiovascular System
Therapeutic Class Cardiovascular System
Subclass Beta-blocking agents
Laboratory Philadelphia Pharma
Category A
Shelf Life 24 months
Generic/Originator Generic
Marketing Authorization Number
Marketing Authorization Date
Range Cardio Metabolic

Reviews

There are no reviews yet.

Be the first to review “EVOCOR 1.25 MG BOX OF 30 ”

Your email address will not be published. Required fields are marked *